Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Justin Zelin is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/09/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | IDYA | Buy Now | IDEAYA Biosciences | $39.60 | 56.57% | $55 → $62 | Maintains | Buy | Get Alert |
| 07/08/2024 | JSPR | Buy Now | Jasper Therapeutics | $21.17 | 325.13% | → $90 | Initiates | → Buy | Get Alert |
| 05/16/2024 | TCRX | Buy Now | TScan Therapeutics | $5.82 | 106.19% | → $12 | Initiates | → Buy | Get Alert |
| 05/06/2024 | LYRA | Buy Now | Lyra Therapeutics | $0.27 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 04/11/2024 | CARM | Buy Now | CARISMA Therapeutics | $1.10 | 445.45% | → $6 | Initiates | → Buy | Get Alert |
| 03/26/2024 | VKTX | Buy Now | Viking Therapeutics | $51.20 | 144.14% | $100 → $125 | Maintains | Buy | Get Alert |
| 03/15/2024 | VKTX | Buy Now | Viking Therapeutics | $51.20 | 95.31% | $86 → $100 | Maintains | Buy | Get Alert |
| 03/08/2024 | IDYA | Buy Now | IDEAYA Biosciences | $39.60 | 38.89% | → $55 | Initiates | → Buy | Get Alert |
| 12/26/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | — | Downgrade | Buy → Neutral | Get Alert |
| 11/21/2023 | VSTM | Buy Now | Verastem | $2.73 | 889.01% | → $27 | Assumes | → Buy | Get Alert |
| 10/06/2023 | LYRA | Buy Now | Lyra Therapeutics | $0.27 | 5507.48% | → $15 | Assumes | → Buy | Get Alert |
| 08/15/2023 | MBIO | Buy Now | Mustang Bio | $0.46 | 3344.56% | $20 → $16 | Maintains | Buy | Get Alert |
| 08/11/2023 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 142.93% | $85 → $91 | Maintains | Buy | Get Alert |
| 08/10/2023 | ACET | Buy Now | Adicet Bio | $1.23 | 716.33% | $20 → $10 | Maintains | Buy | Get Alert |
| 07/25/2023 | PROK | Buy Now | ProKidney | $2.22 | 620.72% | → $16 | Initiates | → Buy | Get Alert |
| 07/03/2023 | ETNB | Buy Now | 89bio | $7.89 | 368.95% | $30 → $37 | Maintains | Buy | Get Alert |
| 06/26/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $21.14 | 65.56% | $34 → $35 | Maintains | Buy | Get Alert |
| 06/16/2023 | MBIO | Buy Now | Mustang Bio | $0.46 | 4205.71% | $4 → $20 | Maintains | Buy | Get Alert |
| 06/13/2023 | LEGN | Buy Now | Legend Biotech | $46.56 | 93.3% | $85 → $90 | Maintains | Buy | Get Alert |
| 06/13/2023 | GRCL | Buy Now | Gracell Biotechnologies | — | — | $18 → $20 | Maintains | Buy | Get Alert |
| 05/17/2023 | KURA | Buy Now | Kura Oncology | $19.99 | 55.08% | → $31 | Initiates | → Buy | Get Alert |
| 05/16/2023 | VKTX | Buy Now | Viking Therapeutics | $51.20 | -29.69% | $31 → $36 | Maintains | Buy | Get Alert |
| 04/20/2023 | LEGN | Buy Now | Legend Biotech | $46.56 | 82.56% | $75 → $85 | Maintains | Buy | Get Alert |
| 03/29/2023 | VKTX | Buy Now | Viking Therapeutics | $51.20 | -39.45% | $20 → $31 | Maintains | Buy | Get Alert |
| 03/28/2023 | NVO | Buy Now | Novo Nordisk | $141.07 | -78.03% | $10 → $15.5 | Maintains | Buy | Get Alert |
| 12/06/2022 | MEIP | Buy Now | MEI Pharma | $2.82 | — | — | Downgrade | Buy → Neutral | Get Alert |
| 11/16/2022 | CASI | Buy Now | CASI Pharmaceuticals | $6.64 | 50.49% | $21 → $10 | Maintains | Buy | Get Alert |
| 11/16/2022 | MBIO | Buy Now | Mustang Bio | $0.46 | 761.14% | $120 → $60 | Maintains | Buy | Get Alert |
| 08/02/2022 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 126.91% | → $85 | Initiates | → Buy | Get Alert |
| 06/29/2022 | ETNB | Buy Now | 89bio | $7.89 | 204.18% | $28 → $24 | Maintains | Buy | Get Alert |
| 06/03/2022 | CASI | Buy Now | CASI Pharmaceuticals | $6.64 | 216.03% | $4 → $21 | Maintains | Buy | Get Alert |
| 04/04/2022 | GRCL | Buy Now | Gracell Biotechnologies | — | — | → $18 | Initiates | → Buy | Get Alert |
| 03/25/2022 | MEIP | Buy Now | MEI Pharma | $2.82 | 41.83% | $220 → $80 | Maintains | Buy | Get Alert |
